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Purpose
To evaluate the frequency of ARI and IL in JIA patients
and its impact on disease activity, and to assess immu-
nogenicity, safety and effectiveness of Flu vaccine in JIA
patients using immunosuppressive drugs, including anti-
TNFa.
Methods
Surveillance for Flu and other respiratory virus: respira-
tory syncytial virus (RSV), metapneumovirus (MPV),
parainfluenza virus (PIV), bocavirus (Bov), adenovirus
(Adv), rhinovirus (RV) and coronavirus (Cov) was con-
ducted in JIA patients attending a tertiary Pediatric
Rheumatology Clinic from March to August 2007 (61
JIA patients included) and from March to August 2008
(63 JIA patients). Patients presenting signs of ARI and/
or IL had airway secretion collected in a 72hs period, by
combined nasal and pharyngeal swab, and viruses detec-
tion was performed using real time PCR (qPCR). 44 JIA
patients aged 2 to 18 years received trivalent split Flu
vaccine A/Solomon Islands/3/2006, H1N1; A/Brisbane/
10/200, H3N2; B/Florida/2006 (Sanofi Pasteur SA/
Butantan Institute) in 2008. Thirty-one of the patients
(70%) were on MTX or leflunomide and 5 (11%) were
on anti-TNF drugs at the time of vaccination. Clinical
and laboratory evaluation, including ACRPed30 were
performed during the surveillance period, before and
after vaccination. Flu titers were determined by hemag-
glutination inhibition (HI) assay before and 30-40 days
after vaccination. Immune response was defined by
seroconversion (a 4-fold or greater rise in HI antibodies)
and seroprotection (HI titers at least 1:40).
Results
During the surveillance period, 105 ARI episodes were
reported by the patients, and 28 of these episodes
(26,6%) were IL. Of 33 samples collected, 20 (60%) were
positive for at least one respiratory virus: Flu A 25%, Flu
B 5%, RV 30%, Adv 20%, PIV 15%, RSV 10%, Bov 5%,
HCov 5%. Virus co-infections were detected in 15% of
the positive samples. During the same period, 49 JIA
flares were observed and 8 (16%) had a temporal rela-
tionship with ARI without any other plausible cause that
may have triggered the events. Seroprotection rates after
vaccination were higher than 70% (91-100%) for all 3
Flu strains and seroconversion rates exceeded 40% (74-
93%). In general, response to Flu vaccine was not influ-
enced by therapeutic regimens or disease activity, but
patients using anti-TNFa drugs presented lower
response to H1N1 strain. No significant differences were
found in JIA activity index (ACRPed30) after vaccination
and no patient reported IL symptoms during the 6-
month post-vaccine period.
Conclusion
ARI are relatively frequent in JIA patients and can possi-
bly have a role in JIA flares. Trivalent split FLU vaccine
seems to be immunogenic, safe and effective in JIA
patients using immunosuppressive agents and should be
given to all children with JIA.
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